XENETIC BIOSCIENCES, INC. Basic Shares Outstanding (Weighted Average)
XENETIC BIOSCIENCES, INC. (XBIO) reported Basic Shares Outstanding (Weighted Average) of 2.29 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.29M shares, a 48.78% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.29M shares, a 48.56% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.18M shares, a 41.35% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.54M shares, a 0.03% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 1.70M shares, a 10.40% increase from fiscal 2024.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.54M shares, a 0.86% increase from fiscal 2023.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.53M shares, a 7.44% increase from fiscal 2022.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.42M shares, a 86.16% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.29M shares 10-Q · filed 2026-08-06 | 2.29M shares 10-Q · filed 2026-08-06 | 2.26M shares derived: average of 3 quarters · filed 2026-08-06 | 2.08M shares derived: average of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | 2.29M shares 10-Q · filed 2026-05-12 | 2.24M shares derived: average of 2 quarters · filed 2026-05-12 | 2.00M shares derived: average of 3 quarters · filed 2026-05-12 | 1.89M shares derived: average of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | 2.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.86M shares derived: average of 2 quarters · filed 2026-03-12 | 1.75M shares derived: average of 3 quarters · filed 2026-08-06 | 1.70M shares 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | 1.54M shares 10-Q · filed 2025-11-12 | 1.54M shares derived: average of 2 quarters · filed 2026-08-06 | 1.54M shares 10-Q · filed 2025-11-12 | 1.54M shares derived: average of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | 1.54M shares 10-Q · filed 2026-08-06 | 1.54M shares 10-Q · filed 2026-08-06 | 1.54M shares derived: average of 3 quarters · filed 2026-08-06 | 1.54M shares derived: average of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | 1.54M shares 10-Q · filed 2026-05-12 | 1.54M shares derived: average of 2 quarters · filed 2026-05-12 | 1.54M shares derived: average of 3 quarters · filed 2026-05-12 | 1.54M shares derived: average of 4 quarters · filed 2026-05-12 | |||||
| 2024-12-31 | 1.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.54M shares derived: average of 2 quarters · filed 2026-03-12 | 1.54M shares derived: average of 3 quarters · filed 2026-03-12 | 1.54M shares 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | 1.54M shares 10-Q · filed 2025-11-12 | 1.54M shares derived: average of 2 quarters · filed 2025-11-12 | 1.54M shares 10-Q · filed 2025-11-12 | 1.54M shares derived: average of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | 1.54M shares 10-Q · filed 2025-08-12 | 1.54M shares 10-Q · filed 2025-08-12 | 1.54M shares derived: average of 3 quarters · filed 2025-08-12 | 1.54M shares derived: average of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | 1.54M shares 10-Q · filed 2025-05-13 | 1.54M shares derived: average of 2 quarters · filed 2025-05-13 | 1.54M shares derived: average of 3 quarters · filed 2025-05-13 | 1.53M shares derived: average of 4 quarters · filed 2025-05-13 | |||||
| 2023-12-31 | 1.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 1.54M shares derived: average of 2 quarters · filed 2025-03-18 | 1.53M shares derived: average of 3 quarters · filed 2025-03-18 | 1.53M shares 10-K · filed 2025-03-18 | |||||
| 2023-09-30 | 1.53M shares 10-Q · filed 2024-11-12 | 1.53M shares derived: average of 2 quarters · filed 2024-11-12 | 1.52M shares 10-Q · filed 2024-11-12 | 1.52M shares derived: average of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | 1.52M shares 10-Q · filed 2024-08-13 | 1.52M shares 10-Q · filed 2024-08-13 | 1.52M shares derived: average of 3 quarters · filed 2024-08-13 | 1.49M shares derived: average of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | 1.52M shares 10-Q · filed 2024-05-09 | 15.17M shares 10-Q · filed 2023-05-11 | 1.51M shares derived: average of 2 quarters · filed 2024-05-09 | 1.48M shares derived: average of 3 quarters · filed 2024-05-09 | 1.47M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 1.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 1.47M shares derived: average of 2 quarters · filed 2024-03-21 | 1.45M shares derived: average of 3 quarters · filed 2024-03-21 | 1.42M shares 10-K · filed 2024-03-21 | 14.22M shares 10-K · filed 2023-03-22 | ||||
| 2022-09-30 | 1.43M shares 10-Q · filed 2023-11-09 | 14.32M shares 10-Q · filed 2022-11-09 | 1.42M shares derived: average of 2 quarters · filed 2023-11-09 | 1.39M shares 10-Q · filed 2023-11-09 | 13.94M shares 10-Q · filed 2022-11-09 | 7.43M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 1.41M shares 10-Q · filed 2023-08-10 | 14.07M shares 10-Q · filed 2022-08-11 | 1.38M shares 10-Q · filed 2023-08-10 | 13.76M shares 10-Q · filed 2022-08-11 | 9.43M shares derived: average of 3 quarters · filed 2023-08-10 | 9.61M shares derived: average of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | 13.44M shares 10-Q · filed 2023-05-11 | 13.44M shares derived: average of 2 quarters · filed 2023-05-11 | 12.35M shares derived: average of 3 quarters · filed 2023-05-11 | 11.45M shares derived: average of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | 13.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 11.80M shares derived: average of 2 quarters · filed 2023-03-22 | 10.79M shares derived: average of 3 quarters · filed 2023-03-22 | 10.28M shares 10-K · filed 2023-03-22 | |||||
| 2021-09-30 | 10.16M shares 10-Q · filed 2022-11-09 | 9.45M shares derived: average of 2 quarters · filed 2022-11-09 | 9.22M shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 8.75M shares 10-Q · filed 2022-08-11 | 8.75M shares 10-Q · filed 2022-08-11 | |||||||
| 2013-11-30 | 135.00M shares 10-Q · filed 2014-01-10 | 135.00M shares derived: average of 2 quarters · filed 2014-01-10 | 135.00M shares derived: average of 3 quarters · filed 2014-01-10 | 135.00M shares derived: average of 4 quarters · filed 2014-01-10 | |||||
| 2013-08-31 | 135.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | 135.00M shares derived: average of 2 quarters · filed 2013-11-27 | 135.00M shares derived: average of 3 quarters · filed 2013-11-27 | 135.00M shares 10-K · filed 2013-11-27 | |||||
| 2013-05-31 | 135.00M shares 10-Q · filed 2013-07-17 | 135.00M shares derived: average of 2 quarters · filed 2013-07-17 | 135.00M shares 10-Q · filed 2013-07-17 | 134.66M shares derived: average of 4 quarters · filed 2014-01-10 | |||||
| 2013-02-28 | 135.00M shares 10-Q · filed 2013-04-22 | 135.00M shares 10-Q · filed 2013-04-22 | 134.55M shares derived: average of 3 quarters · filed 2014-01-10 | 131.24M shares derived: average of 4 quarters · filed 2014-01-10 | |||||
| 2012-11-30 | 13.50M shares 10-Q · filed 2014-01-10 | 134.33M shares derived: average of 2 quarters · filed 2014-01-10 | 129.99M shares derived: average of 3 quarters · filed 2014-01-10 | 122.49M shares derived: average of 4 quarters · filed 2014-01-10 | |||||
| 2012-08-31 | 255.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | 188.23M shares derived: average of 2 quarters · filed 2013-11-27 | 158.82M shares derived: average of 3 quarters · filed 2013-11-27 | 144.15M shares 10-K · filed 2013-11-27 | 11.42M shares 10-K · filed 2012-12-14 | ||||
| 2012-05-31 | 121.30M shares 10-Q · filed 2013-07-17 | 12.13M shares 10-Q · filed 2012-07-16 | 110.65M shares derived: average of 2 quarters · filed 2013-07-17 | 107.15M shares 10-Q · filed 2013-07-17 | 10.72M shares 10-Q · filed 2012-07-16 | ||||
| 2012-02-29 | 100.00M shares 10-Q · filed 2013-04-22 | 10.00M shares 10-Q · filed 2012-04-24 | 100.00M shares 10-Q · filed 2013-04-22 | 10.00M shares 10-Q · filed 2012-04-24 | |||||
| 2011-11-30 | 10.00M shares 10-Q · filed 2013-01-22 | ||||||||
| 2011-08-31 | 4.09M shares 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |